Treatment outcome in patients with ocular toxocariasis who were followed up for ≥3 months.

N/A = not applicable.
P values were obtained using the Wilcoxon signed-rank test.
* Standardization of uveitis nomenclature (SUN) working group's grading scheme, based on the number of inflammatory cells present in a 1×1 mm slit beam of maximal intensity (grade 0: <1 cell, grade 0.5+: 1–5 cells, grade 1+: 6–15 cells, grade 2+: 16–25 cells, grade 3+: 26–50 cells, grade 4+: >50 cells).
†Recurrence defined as aggravation of ocular inflammation or occurrence of a new granuloma.
‡Number of patients showing symptomatic improvement/number of symptomatic patients at baseline.
**The data on grade of ocular inflammation at the time of diagnosis and three months after the diagnosis were used.